When Worlds Collide: The Theory of Real-World Evidence Meets Reality
The FDA Law Blog
MAY 13, 2024
This guidance, when finalized, will replace the original version of this document finalized in 2017. Based on a review of premarket submissions made in 2012 through 2019, FDA identified 90 examples of 510(k)s, De Novos, HDEs, and PMAs approved/cleared which utilized RWE in support of regulatory decision-making.
Let's personalize your content